|
|
||||||||
INFLAMMATION/IMMUNITY/MEDIATORS
Departments of 1Internal Medicine, 2Molecular and Integrative Physiology, and 3Cell and Developmental Biology, The University of Michigan Medical School, Ann Arbor, Michigan 48109-0362
Submitted 17 December 2003 ; accepted in final form 11 February 2004
The effect of inhibiting nitric oxide (NO) synthase (NOS) or enhancing NO on the course of acute pancreatitis (AP) is controversial, in part because three NOS isoforms exist: neuronal (nNOS), endothelial (eNOS), and inducible (iNOS). We investigated whether inhibition or selective gene deletion of NOS isoforms modified the initiation phase of caerulein-induced AP in mice and explored whether this affected pancreatic microvascular blood flow (PMBF). We investigated the effects of nonspecific NOS inhibition with N
-nitro-L-arginine (L-NNA; 10 mg/kg ip) or targeted deletion of eNOS, nNOS, or iNOS genes on the initiation phase of caerulein-induced AP in mice using in vivo and in vitro models. Western blot analysis was performed to assess eNOS phosphorylation status, an indicator of enzyme activity, and microsphere studies were used to measure PMBF. L-NNA and eNOS deletion, but not nNOS or iNOS deletion, increased pancreatic trypsin activity and serum lipase during the initiation phase of in vivo caerulein-induced AP. L-NNA and eNOS did not affect trypsin activity in caerulein-hyperstimulated isolated acini, suggesting that nonacinar events mediate the effect of NOS blockade in vivo. The initiation phase of AP in wild-type mice was associated with eNOS Thr495 residue dephosphorylation, which accompanies eNOS activation, and a 178% increase in PMBF; these effects were absent in eNOS-deleted mice. Thus eNOS is the main isoform influencing the initiation of caerulein-induced AP. eNOS-derived NO exerts a protective effect through actions on nonacinar cell types, most likely endothelial cells, to produce greater PMBF.
blood flow
This article has been cited by other articles:
![]() |
H. Yang, C. J. Lee, L. Zhang, M. D. Sans, and D. M. Simeone Regulation of transforming growth factor {beta}-induced responses by protein kinase A in pancreatic acinar cells Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G170 - G178. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Reddy, Y. Hao, S.-H. Lee, S. R. Gangireddy, C. Owyang, and M. J. DiMagno Pioglitazone reverses insulin resistance and impaired CCK-stimulated pancreatic secretion in eNOS(-/-) mice: therapy for exocrine pancreatic disorders? Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G112 - G120. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ying and L. J. Hofseth An Emerging Role for Endothelial Nitric Oxide Synthase in Chronic Inflammation and Cancer Cancer Res., February 15, 2007; 67(4): 1407 - 1410. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |